Safety Assessment of Bacteroides uniformis CECT 7771 Isolated from Stools of Healthy Breast-Fed Infants

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Fernández Murga, M Leonor ^a   Sanz, Yolanda ^a  

^a INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLACEBO; PROBIOTIC AGENT; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; BACTERIUM ISOLATION; BACTEROIDES UNIFORMIS; BIOCHEMISTRY; BLOOD ANALYSIS; BODY WEIGHT; BREAST FEEDING; COLONY FORMING UNIT; CONTROLLED STUDY; DOWN REGULATION; FECES; FLUID INTAKE; FOOD INTAKE; GENE EXPRESSION; HISTOLOGY; HUMAN; IMMUNE RESPONSE; INFANT; INFLAMMATION; INOS GENE; INTESTINE MUCOSA; KIDNEY; LIVER; MALE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PANCREAS FUNCTION; PPAR GAMMA GENE; PROTEIN EXPRESSION; RISK ASSESSMENT; TOXICITY TESTING; URINALYSIS; ANIMAL; BACTEROIDES; C57BL MOUSE; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PANCREAS; PATHOGENICITY;

ANIMALS; BACTEROIDES; BREAST FEEDING; CYTOKINES; FECES; HUMANS; INFANT; KIDNEY; LIVER; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE II; PANCREAS; PPAR GAMMA; PROBIOTICS;

EID: 84958213741     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0145503     Document Type: Article

References (39)

1. Neef A, Sanz Y. Future for probiotic in functional food and dietary supplement development, Current Opinion 2013 16: 679-687.
2. Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A. 2013 28: 9066-9071.
3. Gauffin Cano P, Santacruz A, Moya A, Sanz Y. Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat-diet induced obesity. PLoS One. 2012 7: 1-15.
4. Martín R, Miquel S, Ulmer J, Kechaou N, Langella P, Bermúdez-Humarán LG. Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease.Microb Cell Fact. 2013 23: 71-80.
5. Moreno Muñoz JA, Chenoll E, Casinos B, Bataller E, Ramon D. Novel probiotic Bifidobacterium longum subsp. infantis CECT 7210 strain active against Rotavirus Infections. App. Environ. Microb. 2011 77: 8775-8783.
6. Ballonge J. Bifidobacteria and probiotic action. In: Lactic Acid Bacteria-Microbiology and functional aspects. 2nd edition. (Eds Salminen S & Von Wright A.). Marcel Decker, New York, 1998 p. 519.
7. Collins JK, Throton G, Sullivan GO. Selection of probiotic strains for human applications. Int. Dairy Science 1998 8: 487-490.
8. Kumar H, Salminen S, Verhagen H, Rowland I, Heimbach J, Bañares S, et al. Novel probiotics and prebiotics: road to the market. Curr Opin Biotechnol. 2014 8: 99-103.
9. EFSA Panel on Biological Hazards [BIOHAZ]. Statement on the update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA 1: Suitability of taxonomic units notified to EFSA until October 2014. EFSA 2014 12: 3938-3979.
10. Hong PY, Wu JH, Liu WT. Relative abundance of Bacteroides spp. in stools and wastewaters as determined by hierarchical oligonucleotide primer extension. Appl. Environ. Microbiol. 2008 74: 2882-2893. doi: 10.1128/AEM.02568-07 PMID: 18344347
11. Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, Griffin NW, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013 341: 1241-2143.
12. Cullen TW, Schofield WB, Barry NA, Putnam EE, Rundell EA, Trent MS, et al. Gut microbiota. Antimicrobial peptide resistance mediates resilience of prominent gut commensals during inflammation. Science. 2015 9: 170-175.
13. Wang Y, Telesford KM, Ochoa-Repáraz J, Haque-Begum S, Christy M, Kasper EJ, et al. An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signalling. Nat Commun. 2014 21: 4432-4440.
14. Boleij A, Hechenbleikner EM, Goodwin AC, Badani R, Stein EM, Lazarev MG, et al. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin Infect Dis. 2015 15: 208-215.
15. Sánchez E, De Palma G, Capilla A, Nova E, Pozo T, Castillejo G, et al. Influence of environmental and genetic factors linked to celiac disease risk on infant gut colonization by Bacteroides species. Appl Environ Microbiol. 2011 77: 5316-5323. doi: 10.1128/AEM.00365-11 PMID: 21642397
16. Chenoll E, Casinos B, Bataller E, Astals P, Echevarría J, Iglesias JR et al. Novel probiotic Bifidobacterium bifidum CECT 7366 strain active against the pathogenic bacterium Helicobacter pylori. Appl Environ Microbiol. 2011 77: 1335-1343. doi: 10.1128/AEM.01820-10 PMID: 21169430
17. Winer J, Jung CK, Shackel I, Williams PM. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem. 1999 270: 41-49. PMID: 10328763
18. LivakKJ Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T) method. Methods 2001 25: 402-408 PMID: 11846609
19. Lara-Villoslada F, Sierra S, Diaz-Ropero MP, Olivares M and Xaus J. Safety assessment of the human milk-isolated probiotic Lactobacillus salivarious CECT5713, J.Dairy Sci. 2007 90: 3583-3590. PMID: 17638967
20. Playne M. Health claims for probiotics. Food Austr. 1994 46-362.
21. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc. Natl.Acad. Sci U S A. 2005 102: 11070-11075. PMID: 16033867
22. Sanz Y, Rastmanesh R, Agostoni C. Understanding the role of gut microbes and probiotics in obesity: how far are we Pharmacol Res. 2013 69: 144-155. doi: 10.1016/j.phrs.2012.10.021 PMID: 23147032
23. Owen CG, Martin RM, Whincup PH. Effect of infant feeding on the risk of obesity across the life course: a quantitative review of published evidence. Pediatrics 2005 115: 1367-1377. PMID: 15867049
24. Stine KE and Brown TM. Measuring toxicity and assessing risk. In: Principles of toxicology (Eds, Stine KE and Brown TM) CRC Lewis publishers, FL 1996 pp 1-10.
25. Zhou JS, Shu Q, Rtutherfurd KJ, Prasad J, Birtles MJ, Gopal PK, Gill HS. Safety assessment of potential probiotic lactic acid bacterial strains Lactobacillus rhamnosus HN001, Lb. acidophilus HN107 and Bifidobacterium lactis HN019 in BALB/c mice. Int. j. Food Microbiol. 2000 56: 87-96. PMID: 10857928
26. Muñoz-Quesada S, Chenoll E, Veites JM, Genovés S, Maldonado J, Bermudez-Brito et al. Isolation, identification and characterization of three novel probiotic strains (Lactobacillus paracasei CNCM I4034, Bifidobacterium breve CNCM I4035 and Lactobacillus rhamnosus CNCM I4036) from faeces of exclusively breast-fed infants. British J. Nutr. 2013 109: S51-S62.
27. Ford HR, Avanoglu A, Boechat PR, Melgoza D, LumCheong RS, Boyle P, et al. The microenvironment influences the pattern of bacterial translocation in formula-fed neonates. J. Pediatr. Surg 1996 31: 486-489. PMID: 8801297
28. Ank N, Sydenham TV, Iversen LH, Justesen US, Wang M. Characterisation of a multidrug-resistant Bacteroides fragilis isolate recovered from blood of apatient in Denmark using whole-genome sequencing. Int. J. Antimicrob Agents. 2015 46: 117-120. doi: 10.1016/j.ijantimicag.2015.02.024 PMID: 25940770
29. Ma L, Deitich E, Specian R, Steffen E, Berg E. Translocation of Lactobacillus murinus from gastrointestinal tract, Current microbiolog, 1990 80: 177-184.
30. Moreira AP, Texeira TF, Ferreira AB, Peluzio Mdo C, Alfenas Rde C. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr. 2012 108: 801-809. doi: 10. 1017/S0007114512001213 PMID: 22717075
31. Meile L, Le Blay G, Thierry A. Safety assessment of dairy microorganisms: Propionibacterium and Bifidobacterium. Int. J Food Microbiol. 2008 126: 316-320. PMID: 17889391
32. Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2001 34: 637-6503.
33. de Kivit S, Tobin MC, Frosyth CB, Keshavarzian A, Landay AL. Regulation of intestinal immune response trough TLR activation: implications for Pro and prebiotics. Front Immunol. 2014 18: 5-60.
34. Mizel SB, Honko AN, Moors MA, Smith PS, West AP. Induction of macrophage nitric oxide production by Gram-negative flagellin involves signaling via heteromeric Toll-like receptor 5/Toll-like receptor 4 complexes. J Immunol. 2003 15: 6217-6223.
35. Jang BC, Paik JH, Kim SP, Bae JH, Mun KC, Song DK, Cho CH et al. Catalase induces the expression of inducible nitric oxide synthase through activation of NF-kappaB and PI3K signaling pathway in Raw 264.7 cells. Biochem Pharmacol. 2004 1: 2167-2176.
36. Kadowaki S, Chikumi H, Yamamoto H, Yoneda K, Yamasaki A, Sato K, Shimizu E Down-regulation of inducible nitric oxide synthase by lysophosphatidic acid in human respiratory epithelial cells. Mol Cell Biochem. 2004 262: 51-59. PMID: 15532709
37. Davis RL, Sanchez AC, Lindley DJ, Williams SC, Syapin PJ. Effects of mechanistically distinct NF-kappaB inhibitors on glial inducible nitric-oxide synthase expression. Nitric Oxide. 2005 12: 200-209. PMID: 15890551
38. Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, Mazmanian SK. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science. 2011 332: 974-977. doi: 10.1126/science.1206095 PMID: 21512004
39. Kelly D, Campbell JI, King TP, Grant G, Jansson EA, Coutts AG, Pettersson S, Conway S. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPARgamma and Rel A. Nat. Immunol. 2004 5: 104-112. PMID: 14691478